Among these, hyaluronic acid (HA), a negatively charged polysaccharide, has been extensively used for cancer selective drug delivery applications due to overexpressed HA receptors (CD44) in cancer cells.11 The excellent biocompatibility and unique biological characteristics of the polymer make it suitable for these applications. The gene discussed is CD44; the disease is cancer.